When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal

被引:246
作者
Zanchetti, Alberto [1 ,2 ]
Grassi, Guido [1 ,3 ]
Mancia, Giuseppe [1 ,3 ]
机构
[1] Univ Milan, Ist Auxol Italiano, I-20122 Milan, Italy
[2] Univ Milan, Ctr Interuniv Fisiol Clin & Ipertens, I-20122 Milan, Italy
[3] Univ Milan, Osped San Gerardo, Dipartimento Med Clin, Monza, Italy
关键词
antihypertensive therapy; target blood pressure; treatment initiation; trials; LONG-ACTING NIFEDIPINE; RECURRENT STROKE; CARDIOVASCULAR MORBIDITY; HYPERTENSIVE PATIENTS; DIABETES-MELLITUS; OLDER PATIENTS; STABLE ANGINA; TRIAL; MORTALITY; DISEASE;
D O I
10.1097/HJH.0b013e32832aa6b5
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The evidence for two recommendations of all major guidelines on hypertension is critically discussed. The first recommendation is that of initiating antihypertensive drug treatment when systolic blood pressure is at least 140 or diastolic blood pressure at least 90 mmHg in patients with grade 1 hypertension and low or moderate total cardiovascular risk, and even when blood pressure is in the high normal range in patients with diabetes and previous cardiovascular disease. The second recommendation is that of achieving systolic blood pressure levels below 140 mmHg in all hypertensive patients, including the elderly, and values below 130 mmHg in patients having diabetes and high/very-high-risk patients. Critical analyses of the results of available trials show that the evidence is scanty for both recommendations. Nonetheless, they can be accepted as prudent statements, as antihypertensive agents are very well tolerated and lowering systolic blood pressure below 130 mmHg appears well tolerated. However, wisdom should not be taken for evidence, and simple trials should be designed to look for more solid evidence in favour of current recommendations. J Hypertens 27:923-934 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:923 / 934
页数:12
相关论文
共 61 条
[1]   2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension [J].
Afridi, I ;
Canny, J ;
Yao, CH ;
Christensen, B ;
Cooper, RS ;
Kadiri, S ;
Hill, S ;
Kaplan, N ;
Kuschnir, E ;
Lexchin, J ;
Mendis, S ;
Poulter, N ;
Psaty, BM ;
Rahn, KH ;
Sheps, SG ;
Whitworth, J ;
Yach, D ;
Bengoa, R ;
Ramsay, L ;
Kaplan, N ;
Mendis, S ;
Poulter, N ;
Whitworth, J .
JOURNAL OF HYPERTENSION, 2003, 21 (11) :1983-1992
[2]   Basic characteristics of chronic hypotension cases: A longitudinal follow-up study from 1958 through 1999 [J].
Akahoshi, M ;
Hida, A ;
Imaizumi, M ;
Soda, M ;
Maeda, R ;
Ichimaru, S ;
Nakashima, E ;
Seto, S ;
Yano, K .
HYPERTENSION RESEARCH, 2006, 29 (01) :1-7
[3]  
AMERY A, 1985, LANCET, V1, P1349
[4]  
[Anonymous], 1991, JAMA, V265, P3255
[5]  
[Anonymous], 1980, LANCET, V1, P1261
[6]  
[Anonymous], 1979, JAMA-J AM MED ASSOC, V242, P2562
[7]  
[Anonymous], 1982, JAMA, V247, P633
[8]  
[Anonymous], 2000, Lancet, V355, P253, DOI 10.1016/S0140-6736(99)12323-7
[9]   Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial [J].
Arima, Hisatomi ;
Chalmers, John ;
Woodward, Mark ;
Anderson, Craig ;
Rodgers, Anthony ;
Davis, Stephen ;
MacMahon, Stephen ;
Neal, Bruce .
JOURNAL OF HYPERTENSION, 2006, 24 (06) :1201-1208
[10]   Treatment of hypertension in patients 80 years of age or older [J].
Beckett, Nigel S. ;
Peters, Ruth ;
Fletcher, Astrid E. ;
Staessen, Jan A. ;
Liu, Lisheng ;
Dumitrascu, Dan ;
Stoyanovsky, Vassil ;
Antikainen, Riitta L. ;
Nikitin, Yuri ;
Anderson, Craig ;
Belhani, Alli ;
Forette, Francoise ;
Rajkumar, Chakravarthi ;
Thijs, Lutgarde ;
Banya, Winston ;
Bulpitt, Christopher J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18) :1887-1898